B. Riley Starts CytoSorbents (CTSO) at Buy
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
B. Riley initiated coverage on CytoSorbents (NASDAQ: CTSO) with a Buy rating and a price target of $11.25.
Shares of CytoSorbents closed at $5.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CytoSorbents to Present at the LD Micro Main Event Investor Conference
- UPDATE: Oppenheimer Starts Paycom Software (PAYC) at Outperform
- Dougherty & Co Starts athenahealth (ATHN) at Buy
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesB. Riley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!